Anthony S. Fiorino Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anthony S. Fiorino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony S. Fiorino. Anthony S. Fiorino is a Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and an Chief Executive Officer in BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) and a Chief Medical Officer and COO in IMMUNE PHARMACEUTICALS INC ($IMNP) and a Director in IMMUNE PHARMACEUTICALS INC ($IMNP).
Address: C/O BRAINSTORM CELL THERAPEUTICS INC. 605 THIRD AVENUE, 34TH FLOOR NEW YORK 10158 NY
Companies in which Anthony S. Fiorino is an Insider
BRAINSTORM CELL THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anthony S. Fiorino: Chief Executive Officer
Holdings: 18,000 shares
Current Value: $57,960
Latest Transaction: Sep 16 2014
$BCLI Market Capitalization: $60.17M
$BCLI Previous Close: $3.22
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anthony S. Fiorino: Director, Chief Medical Officer and COO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 04 2020
$IMNP Market Capitalization: $23.82M
$IMNP Previous Close: $0.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Anthony S. Fiorino: Director
Holdings: 78,000 shares
Current Value: $40,560
Latest Transaction: Jun 30 2017
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Anthony S. Fiorino
Sentiment: All, BCLI, IMNP, NAVB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2020 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Director | Sell | S | 0.00 | 75,000 | 263 | 0 | 75 K to 0 (-100.00 %) |
| May 23 2018 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Buy | P | 0.24 | 25,000 | 5,978 | 75,000 | 50 K to 75 K (+50.00 %) |
| May 18 2018 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Buy | P | 0.26 | 50,000 | 12,900 | 50,000 | 0 to 50 K |
| Sep 18 2017 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Option Exercise | A | 1.10 | 90,000 | 99,000 | 90,000 | |
| Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Fiorino Anthony S. | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
| Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Fiorino Anthony S. | Director | Grant | A | 0.00 | 50,000 | 50 | 78,000 | 28 K to 78 K (+178.57 %) |
| Apr 29 2016 | NAVB | NAVIDEA BIOPHARMAC ... | Fiorino Anthony S. | Director | Grant | A | 0.00 | 28,000 | 0 | 28,000 | 0 to 28 K |